Frequency of blood tests in heart surgery patients may lead to anemia, transfusions

Key points
- Laboratory testing among patients undergoing cardiac surgery can lead to excessive bloodletting, which can increase the risk of developing hospital-acquired anemia and the need for blood transfusion, according to an article in the March 2015 issue of The Annals of Thoracic Surgery.
- Excessive lab tests prior to and following cardiac surgery can lead to excessive bloodletting, which can increase the risk of developing hospital-acquired anemia and the need for transfusion during surgery.
- In an invited commentary in the same issue of The Annals, Milo Engoren, MD, from the University of Michigan in Ann Arbor, emphasized the importance of reducing blood loss to decrease possible complications during surgery.
- The study found that heart surgery patients had an average of 116 lab tests while in the hospital.
Laboratory testing among patients undergoing cardiac surgery can lead to excessive bloodletting, which can increase the risk of developing hospital-acquired anemia and the need for blood transfusion, according to an article in the March 2015 issue of The Annals of Thoracic Surgery.
Key points
Excessive lab tests prior to and following cardiac surgery can lead to excessive bloodletting, which can increase the risk of developing hospital-acquired anemia and the need for transfusion during surgery.
The study found that heart surgery patients had an average of 116 lab tests while in the hospital.
Patients should ask their doctors whether a specific test is necessary.
"Prior research shows that patients who receive blood transfusions during heart surgery have more infections after surgery, spend more time on the ventilator, and die more frequently--even after adjusting for how sick they were prior to surgery," said Colleen G. Koch, MD, MS, MBA, from the Cleveland Clinic in Ohio, who led the current study.
Dr. Koch and colleagues examined every laboratory test from 1,894 patients who underwent cardiac surgery from January to June 2012 at the Cleveland Clinic. The number and type of blood tests performed were recorded from the time patients met their surgeons until hospital discharge. The researchers then tallied up the total amount of blood taken from each patient.
Results showed a total of 221,498 laboratory tests were performed during the study period, which equaled 116 tests per patient. Cumulative median phlebotomy volume for the entire hospital stay was 454 mL per patient. Phlebotomy volume differed between the intensive care unit (ICU) and other hospital floors, with ICU patients having more blood drawn, on average (332 mL vs. 118 mL).
"We were astonished by the amount of blood taken from our patients for laboratory testing. Total phlebotomy volumes approached 1 to 2 units of red blood cells, which is roughly equivalent to 1 to 2 cans of soda" said Dr. Koch.
More complex procedures were associated with higher overall phlebotomy volume. Patients undergoing combined coronary artery bypass grafting surgery and valve procedures had the highest median cumulative phlebotomy volume.
The findings also noted that as the cumulative phlebotomy volume increased, so did the need for blood products. Similarly, the longer a patient was hospitalized, the more blood was taken, which increased the subsequent need for a red blood cell transfusion.
"Patients should feel empowered to ask their doctors whether a specific test is necessary - 'What is the indication for the test?,' ' Will it change my care?,' and 'If so, do you need to do it every day?,'" said Dr. Koch. "They should inquire whether smaller volume test tubes could be used for the tests that are deemed necessary. Every attempt should be made to conserve the patient's own blood - every drop of blood counts."
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Heart & Blood Vessels →
NewsMerck Blood Thinner Stops Heart Attacks With Risk of Bleeding
A study of an experimental blood thinner from Merck & Co. (MRK) showed that while the drug helped thwart heart attacks it raised the risk of brain bleeding, a side effect that could stymie its approval. The three-year…
27 March 2012
NewsNew ability to regrow blood vessels holds promise for treatment of heart disease
University of Texas at Austin researchers have demonstrated a new and more effective method for regrowing blood vessels in the heart and limbs - a research advancement that could have major implications for how we treat…
18 February 2012
NewsTests for biomarker may help determine diagnosis of heart attack within hours
For patients admitted to an emergency department with chest pain, use of a contemporary or highly sensitive test for levels of troponin I (a protein in muscle tissue) may help rule-out a diagnosis of heart attack, while…




